Donate For Public and Patients Store Search

Go to AAD Home

Clinical guidance for COVID-19

COVID-19 updates

The Academy’s Ad Hoc Task Force on COVID-19 is monitoring pandemic developments daily, assessing the impact on practices, and providing guidance most relevant to dermatologists. The most current information is being posted to these pages as we have it. Check back for updates.

Access Academy resources designed to answer common dermatology questions during the COVID-19 pandemic.

Running your dermatology practice during COVID-19

Review steps you should take to protect yourself, your staff, and your patients.

PPE and medical supplies

Access Academy advice and FDA guidance on conserving supplies of PPE and other medical supplies.

Immunosuppressive therapies

Review information and documents on continuing immunosuppressive therapies, including biologics, during the COVID-19 pandemic.

iPLEDGE and isotretinoin

Read FDA guidance on flexibility in meeting iPLEDGE requirements during the emergency.

Academy publications on COVID-19

Access Academy statements and publications on COVID-19, including DermWorld and JAAD articles.

Other clinical guidance

Wondering what guidance other organizations are providing? The AAD has assembled links to guidance from the AMA and other organizations.

Prior authorization changes

Dermatology-specific changes to prior authorization policies due to COVID-19.

Skin cancer screening during the COVID-19 pandemic

The AAD has developed guidance on individual and mass skin cancer screenings during the pandemic. Download the PDF.

Navigate the Coronavirus Resource Center

All content solely developed by the American Academy of Dermatology

Supported by:

Lilly logo
bristol myers squibb logo
Abbvie logo
Amgen logo